Metastatic Cancers
Table of Contents
Metastatic Cancers Explained
Metastatic cancer refers to cancer that has spread from its original (primary) site to other parts of the body. This type of cancer is also called stage IV or advanced cancer. While metastatic cancer can affect various organs and tissues, it is still named after the primary cancer (e.g., metastatic breast cancer).
How Metastasis Happens
Metastasis involves the movement of cancer cells from the original tumor to other parts of the body through:
- Bloodstream: Cancer cells enter blood vessels and travel to distant sites.
- Lymphatic system: Cancer cells spread through lymph nodes and the lymphatic network.
Once cancer cells reach a new location, they may grow and form new tumors that interfere with the function of the affected organs.
Common Sites for Metastasis
Cancer can metastasize to almost any part of the body, but some common sites include:
- Lungs
- Liver
- Bones
- Brain
- Lymph nodes
Symptoms of Metastatic Cancers
The symptoms of metastatic cancer depend on the location of the metastasis and may include:
- Lung metastasis: Shortness of breath, chest pain, and persistent cough.
- Liver metastasis: Jaundice, abdominal pain, and loss of appetite.
- Bone metastasis: Bone pain, fractures, and high calcium levels.
- Brain metastasis: Headaches, seizures, and neurological symptoms such as dizziness or vision problems.
Diagnosis of Metastatic Cancer
Diagnostic Procedures
Diagnosis may involve a range of tests, including:
- Imaging tests: Such as computed tomography (CT) scans, magnetic resonance imaging (MRI), positron emission tomography (PET) scans, and X-rays to locate metastases.
- Biopsy: Taking a tissue sample from the metastatic site to confirm cancer type.
- Blood tests: To check for markers that indicate the spread of cancer.
Treatment Options
Treatment for metastatic cancer focuses on controlling the spread, relieving symptoms, and improving quality of life. Options may include:
- Systemic therapies: Such as chemotherapy, targeted therapy, immunotherapy, and hormone therapy to address cancer throughout the body.
- Radiation therapy: Used to reduce pain and manage symptoms in specific areas. High-precision radiation (stereotactic ablative radiotherapy, SABR) has also been aimed at every metastasis in people with only a few. In the SABR-COMET phase 2 trial of 99 people whose primary cancer was controlled and who had 1–5 metastases, adding SABR to standard care raised 5-year survival from 17.7% to 42.3%, with no new moderate-to-severe (grade 2–5) side effects during the longer follow-up and no difference in quality of life. Because this was a phase 2 trial, larger phase 3 trials are testing the approach.
- Surgery: Sometimes performed to remove metastatic tumors if feasible.
- Palliative care: Aims to enhance comfort and support during treatment by managing pain and other symptoms. In a 2010 trial of 151 people with newly diagnosed metastatic non-small-cell lung cancer, adding palliative care from the time of diagnosis improved quality of life and reduced depressive symptoms (16% vs 38%). Fewer of these patients received aggressive care at the end of life (33% vs 54%), yet their median survival was longer (11.6 vs 8.9 months).
Prognosis
The prognosis for metastatic cancer varies widely based on factors such as the type of primary cancer, location and number of metastases, and response to treatment. Although metastatic cancer is generally considered incurable, advancements in treatment have improved survival rates and quality of life for many patients.
Two trials show what this can mean in numbers. Some people have only a few metastases, a state doctors call oligometastatic cancer; the idea being tested is that treating every site may give long-term control. In the SABR-COMET trial (1–5 metastases, primary cancer already controlled), 42.3% of people who also received high-precision radiation to every metastasis were alive at 5 years, against 17.7% with standard care alone. In metastatic non-small-cell lung cancer, people who received palliative care from diagnosis lived a median of 11.6 months, against 8.9 months with standard cancer care alone, while also reporting better quality of life.
Key Research Papers
Historical Background
The concept of metastasis was first described by French surgeon Joseph Recamier in 1829, who coined the term to describe the spread of cancer from one organ to another. Stephen Paget's "seed and soil" hypothesis of 1889, proposing that cancer cells (seeds) preferentially colonize certain organs (soil), remains a foundational concept in metastasis research. Isaiah Fidler's work in the 1970s further established the biology of tumor heterogeneity and metastatic colonization.
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674. — doi:10.1016/j.cell.2011.02.013
- Massague J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529(7586):298-306. — doi:10.1038/nature17038
- Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443-2454. — doi:10.1056/NEJMoa1200690
- Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559-1564. — doi:10.1126/science.1203543
- Andre F, Ciruelos E, Rubovszky G, et al. Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer (SOLAR-1). N Engl J Med. 2019;380(20):1929-1940. — doi:10.1056/NEJMoa1813904
- Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670-691. — doi:10.1016/j.cell.2016.11.037
- Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer (CheckMate 017). N Engl J Med. 2015;373(2):123-135. — doi:10.1056/NEJMoa1504627
- Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET). The Lancet. 2019;393(10185):2051-2058. — doi:10.1016/S0140-6736(18)32487-5
- Turajlic S, Sottoriva A, Graham T, Swanton C. Resolving genetic heterogeneity in cancer. Nat Rev Genet. 2019;20(7):404-416. — doi:10.1038/s41576-019-0114-6
- Ganesh K, Massague J. Targeting metastatic cancer. Nat Med. 2021;27(1):34-44. — doi:10.1038/s41591-020-01195-4
- Swain SM, Baselga J, Kim SB, et al. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer (CLEOPATRA). N Engl J Med. 2015;372(8):724-734. — doi:10.1056/NEJMoa1413513
- Pantel K, Alix-Panabieres C. Liquid biopsy and minimal residual disease: latest advances and implications for cure. Nat Rev Clin Oncol. 2019;16(7):409-424. — doi:10.1038/s41571-019-0187-3
- Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020;38(25):2830-2838. — doi:10.1200/JCO.20.00818
- Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742. — doi:10.1056/NEJMoa1000678
PubMed Topic Searches
The following PubMed topic searches surface the current peer-reviewed literature on Metastatic Cancer. Each link opens a live PubMed query; results update as new papers are indexed.
- PubMed: Search: metastatic cancer
- PubMed: Search: cancer metastasis mechanism
- PubMed: Search: bone metastasis
- PubMed: Search: brain metastasis treatment
- PubMed: Search: liver metastasis
- PubMed: Search: lung metastasis
- PubMed: Search: circulating tumor cells metastasis
- PubMed: Search: metastatic cancer immunotherapy
- PubMed: Search: metastatic cancer targeted therapy
- PubMed: Search: oligometastatic disease SBRT
- PubMed: Search: metastatic cancer palliative care
- PubMed: Search: metastasis tumor microenvironment
Connections
- Oncology
- Cancer Overview
- Sarcoma
- Multiple Myeloma
- Thyroid Cancer
- Leukemia
- Lymphoma
- Turmeric
- Vitamin D3
- Pleural Effusion
- Gerson Therapy Cancer Treatment
- Kidney Disease
- Shortness of Breath
- Jaundice
- Loss of Appetite
- Cancer Prevention
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Pancreatic Cancer
- Skin Cancer
- Ovarian Cancer
- Cervical Cancer
- Liver Cancer
- Stomach Cancer
- Esophageal Cancer
- Kidney Cancer
- Endometrial Cancer